1536.00 - 1565.00
1090.00 - 1784.00
46.2K / 155.6K (Avg.)
23.48 | 66.41
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-33.30%
Negative revenue growth while 6203.T stands at 3.65%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-39.40%
Negative gross profit growth while 6203.T is at 24.46%. Joel Greenblatt would examine cost competitiveness or demand decline.
-3529.69%
Negative EBIT growth while 6203.T is at 2787.50%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-1904.15%
Negative operating income growth while 6203.T is at 355.81%. Joel Greenblatt would press for urgent turnaround measures.
-262.13%
Negative net income growth while 6203.T stands at 9400.00%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-262.21%
Negative EPS growth while 6203.T is at 8923.53%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-262.21%
Negative diluted EPS growth while 6203.T is at 8923.53%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-47.25%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-28.34%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-14.36%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
-100.00%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-56.57%
Negative 10Y net income/share CAGR while 6203.T is at 96.24%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-177.11%
Negative 5Y net income/share CAGR while 6203.T is 1029.65%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-149.97%
Negative 3Y CAGR while 6203.T is 243.30%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
369.43%
10Y equity/share CAGR above 1.5x 6203.T's 43.28%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
47.76%
Positive 5Y equity/share CAGR while 6203.T is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
12.62%
3Y equity/share CAGR above 1.5x 6203.T's 1.51%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
1.86%
AR growth is negative/stable vs. 6203.T's 13.96%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
13.08%
Inventory growth well above 6203.T's 3.83%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
6.98%
Asset growth above 1.5x 6203.T's 3.83%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
-3.56%
We have a declining book value while 6203.T shows 0.92%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
19.32%
Debt shrinking faster vs. 6203.T's 43.17%. David Dodd sees a safer balance sheet if it doesn't impair future growth.
No Data
No Data available this quarter, please select a different quarter.
-2.35%
We cut SG&A while 6203.T invests at 2.18%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.